Article
Follow-up studies of treatment for hepatitis C virus infection among injection drug users.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Apr 2005
Dalgard Olav
Abstract excerpt
Physicians are reluctant to treat chronic hepatitis C virus (HCV) infection in active injection drug users (IDUs). An important reason for this is concern about reinfection after successful treatment. However, little is known about this apparent risk; because of lack of protective immunity, reinf...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
